CN105535117A - 一种治疗湿疹的解毒制剂 - Google Patents
一种治疗湿疹的解毒制剂 Download PDFInfo
- Publication number
- CN105535117A CN105535117A CN201610018307.3A CN201610018307A CN105535117A CN 105535117 A CN105535117 A CN 105535117A CN 201610018307 A CN201610018307 A CN 201610018307A CN 105535117 A CN105535117 A CN 105535117A
- Authority
- CN
- China
- Prior art keywords
- parts
- eczema
- treatment
- preparation
- detoxicating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 57
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 15
- 241000628997 Flos Species 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims description 38
- 241000124079 Mylabris Species 0.000 claims description 12
- 241000522620 Scorpio Species 0.000 claims description 12
- 239000009490 scorpio Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 210000004185 liver Anatomy 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 208000003322 Coinfection Diseases 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001481669 Meloidae Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 description 40
- 206010000496 acne Diseases 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 210000003414 extremity Anatomy 0.000 description 11
- 230000001154 acute effect Effects 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 206010040844 Skin exfoliation Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 206010040882 skin lesion Diseases 0.000 description 8
- 231100000444 skin lesion Toxicity 0.000 description 8
- 240000008042 Zea mays Species 0.000 description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 7
- 235000005822 corn Nutrition 0.000 description 7
- 230000035618 desquamation Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 210000005069 ears Anatomy 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 241000272814 Anser sp. Species 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- 210000004247 hand Anatomy 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 238000005096 rolling process Methods 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000006748 scratching Methods 0.000 description 4
- 230000002393 scratching effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 210000003423 ankle Anatomy 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241001656472 Epinephelus morio Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010024438 Lichenification Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 241000324343 Causa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000003211 Corylus maxima Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001662443 Phemeranthus parviflorus Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039740 Screaming Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 206010041955 Stasis dermatitis Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960000673 dextrose monohydrate Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000009525 mild injury Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
一种治疗湿疹的解毒制剂,是由如下重量份数的原料组成的:柴胡1~15份、黄芪3~30份、金银花1~15份、连翘1~15份、斑蝥0.5~10份、蝎子1~30份。所述治疗湿疹的解毒制剂为胶囊剂、散剂等。本发明提供的治疗湿疹的解毒制剂,组方的六味中药配伍规律基于中医基本理论,其配方切中湿疹的中医病因、病机,且制备工艺简单,以“止痛,消炎,防止继发感染和缩短病程”为治疗基本原则,经临床验证具有疏肝理气健脾,清热解毒,活血,散结消肿止痛的功效,对湿疹效果显著,有效提高患者的生活质量。
Description
技术领域
本发明涉及中医药技术领域,尤其涉及一种治疗湿疹的解毒制剂。
背景技术
湿疹,是由多种内外因素引起的瘙痒剧烈的一种皮肤炎症反应。分急性、亚急性、慢性三期。急性期具渗出倾向,慢性期则浸润、肥厚。有些病人直接表现为慢性湿疹。湿疹是皮肤科中最常见的一类皮肤病,不管男女老幼,不管什么季节,都可以发生。发生时患者瘙痒剧烈,在急性期以丘疱疹为主,在慢性期以表皮肥厚和苔藓样变为主。皮损可以局限发疹,也可以泛发全身。患者的皮疹往往对称分布,形态多种多样。原发的皮损可有红斑、丘疹、水疱,继发的皮损具有抓痕、结痂、糜烂、渗出或苔藓样皮肤增厚。
湿疹是复杂的内外因子引起的一种迟发型变态反应,其病因复杂,常为内外因相互作用结果。内因如慢性消化系统疾病、精神紧张、失眠、过度疲劳、情绪变化、内分泌失调、感染、新陈代谢障碍等,外因如生活环境、气候变化、食物等均可影响湿疹的发生。外界刺激如日光、寒冷、干燥、炎热、热水烫洗以及各种动物皮毛、植物、化妆品、肥皂、人造纤维等均可诱发。湿疹往往反复发作,如病因不除则易趋于慢性。因此,湿疹的治疗十分棘手。
中医外治法有着悠久的历史和确切的疗效,对于湿疹治疗,同样如此。湿疹外治需要考虑剂型的选择:急性亚急性湿疹渗液较多时,多用煎剂湿敷;渗出不多时,多选用散剂外扑或麻油调敷;而慢性湿疹,皮肤肥厚苔藓样变,则选用熏洗剂或软膏、乳剂等剂型,药选养血润燥之品。
发明内容
本发明的目的在于提供一种治疗湿疹的解毒制剂,具有疏肝理气健脾,清热解毒,活血,散结消肿止痛的功效,治疗湿疹效果显著。
为实现本发明的上述目的,本发明提供一种治疗湿疹的解毒制剂,是由如下重量份数的原料组成的:柴胡1~15份、黄芪3~30份、金银花1~15份、连翘1~15份、斑蝥0.5~10份、蝎子1~30份。
所述治疗湿疹的解毒制剂的制备方法为:按配方重量份数将柴胡、黄芪、金银花、连翘大火烧开,小火煎30min,反复煎煮三次,合并药汁,浓缩后干燥打粉,用20~80目过筛,得混合粉;再按照配方重量份数将斑蝥、蝎子打粉,用20~80目过筛后,与所述混合粉混匀,灌装成胶囊(2号),每粒约0.553g。
所述治疗湿疹的解毒制剂为胶囊剂、散剂等。
在本发明的组方中。
柴胡:辛、苦,微寒;归肝、胆、肺经。疏散退热,疏肝解郁,升举阳气。用于感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛。
黄芪:味甘、性微温;归肺、脾、肝、肾经。补齐固表,托疮生肌。主治体虚自汗,久泻,脱肛,子宫脱垂,慢性肾炎,体虚浮肿,慢性溃疡,疮口久不愈合。
金银花:甘,寒;归肺、心、胃、大肠经。清热解毒,疏散风热。主治:用于外感风热,温病发热,痈肿疮疡,咽喉肿痛,热毒痢疾。
连翘:性味苦,微辛,寒;归肺、胃、心、小肠经。清热解毒,疏风热,清心热。
斑蝥:味辛、性温、有毒;入大肠、小肠、肝、肾经。《本草经疏》:入手阳明、手太阳经。《玉楸药解》:入足厥阴肝经。《会约医镜》:入肺、脾二经。《本草再新》:入肝、脾、肾三经。肾经攻毒蚀疮;逐瘀散结痈疽;瘰疬;顽癣;经闭;癥瘕;癌肿攻毒蚀疮;逐瘀散结。主痈疽;瘰疬;顽癣;经闭;症瘕;癌肿。用于癓瘕肿块,积年顽癣,瘰疬,赘疣,痈疽不溃,恶疮死肌。
蝎子:性味辛、平;有毒,归肝经。功能主治祛风,止痉,通络,解毒。治惊风抽摘,癫痫,中风、半身不遂、口眼歪斜,偏头痛,风湿痹痛,破伤风,淋巴结结核,风疹疮肿。
与现有技术相比本发明的有益效果。
本发明提供的治疗湿疹的解毒制剂,组方的六味中药配伍规律基于中医基本理论,其配方切中湿疹的中医病因、病机,且制备工艺简单,以“止痛,消炎,防止继发感染和缩短病程”为治疗基本原则,经临床验证具有疏肝理气健脾,清热解毒,活血,散结消肿止痛的功效,对湿疹效果显著,有效提高患者的生活质量。
具体实施方式
下面结合具体实施例进一步详细说明本发明。
实施例1。
本实施例提供一种治疗湿疹的解毒制剂,是由如下重量份数的原料组成的:柴胡5份、黄芪10份、金银花5份、连翘5份、斑蝥0.5份、蝎子10份。
所述治疗湿疹的解毒制剂为胶囊剂,其制备方法为:按配方重量份数将柴胡、黄芪、金银花,连翘大火烧开,小火煎30min,反复煎煮三次,合并药汁,浓缩后干燥打粉,用80目过筛,得混合粉;再按照配方重量份数将斑蝥,蝎子打粉,用80目过筛后,与所述混合粉混匀制备成散剂,然后灌装成2号胶囊,每粒胶囊约0.553克,按照病情每次服用2~5粒,儿童减半,每日三次口服。
采用本实施例解毒胶囊治疗湿疹的典型病例。
1、刘某,男,43岁。初诊:风湿热兼浸两耳,疮痍破津,蔓延全身,更发垒,宜清热消风。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,十日后痊愈。
2、钱某,男,46岁。初诊:四弯风肢酸发痒,双肘窝处红肿瘙痒剧烈,伴有渗出。脉见细弦,肺脾为患。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,十日后痊愈。
3、徐某,男,36岁。初诊:四弯风拳至不仁,脉见细弦,属气痹营伤,拟药酒方。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,十日后痊愈。
4、唐某,女,22岁。初诊:产后营亏生风,风邪挟湿走窜经隧,两足酸软,膝盖肿势虽退,仍伸而难屈,两手亦为发麻,将成四弯风,脉见细弦,治以疏和。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,13日后痊愈。
5、徐某,男,23岁。初诊:湿瘰发于遍体,浸淫作痒,延今已久。血虚生热生风,脾弱生湿,风湿热蕴蒸于脾肺两经也。姑拟清营祛风,而化湿热。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,两月后痊愈。
6、王某,女,2岁。初诊:湿毒胎火,蕴袭脾肺两经,遍体湿疮,浸淫痒痛,头颅尤甚,身热嗽,入夜惊悸,虑其增剧,宜清化消毒。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,15日后痊愈。
7、邓某,女,78岁,2012年6月17日初诊。初诊:一二年来常起皮肤湿疹,近3个月更甚,以四肢较多,开始散在全身,以后逐成片状增多,发痒,搔破后流黄水,无发热,饮食尚佳,睡眠不实,大小便正常,脉沉弦细数,舌质正常,中心白黄苔腻,属脾湿化热,兼血燥生风,治宜养血清热,祛风除湿。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,45天后痊愈。
8、赵某某,男,50岁,干部,2013年11月8日初诊。初诊:自2013年开始,下肢皮肤起湿疹,痒甚,每年秋后要发作1次,经各种治疗未能根除,后来每次发作逐渐向上蔓延,目前颈部亦起湿疹,其形似癣,成片,痒甚,搔后皮肤破溃流黄水,食欲及小便正常,大便经常干燥,平时喜饮酒,嗜厚味,脉缓,左关微弦,舌质正常,苔薄白微腻,由湿热兼风,蕴藏皮下,久则化燥,皮溃风乘,证属风湿,治宜祛风除湿,从阳明太阴为主。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,两月后痊愈。
9、赵某,男,2个月。初诊:近日乳食欠佳,时多呕逆,颜面起有湿疹渗出作痒,大小便尚好,指纹淡紫至风关,舌苔白滑,为湿浊内潜,胃腑不清,乳滞内热复感风邪,发为湿疹,治以疏风利湿清热。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,11日后痊愈。
10、陈某,女,2个月。初诊:皮肤起湿疹,时多作痒,剧则流水,关纹内隐。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,13日后痊愈。
11、宋某某,女,64岁,2010年3月29日初诊。初诊:肝郁湿热内潜,皮肤起疹,湿毒作痒,有时畏寒增热,脉象数沉。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,10日后痊愈。
12、朱某某,女,20岁,2014年2月19日初诊。初诊:两手掌作痒、作胀、脱皮,血虚湿热入营之故。治予祛风凉营而化湿热。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,15日后痊愈。
13、丁某某,女,十八岁,2015年6月2日初诊。初诊:大便不爽,湿疹瘙痒。以润腑化湿热法治之。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,10日后痊愈。
14、刘某.男,72岁,工人,2011年6月11日初诊。初诊:患者于10年前无明显诱因出现双下肢肿胀、沉困,继之双下肢及足部出现密集的米粒大红色丘疹及小水疱,瘙痒异常,破则流水,经某职工医院诊为“静脉曲张性湿疹”,经多方治疗未见效。近来病情日渐加重,不能坚持工作,遂于2011年6月11日由其子扶持前来求治。诊时其两下肢及足部肿胀如柱,皮肤粗糙呈暗灰色,疼痛瘙痒,破处流水,结痂之处皮肤顽痹,麻木不仁,大便干结,小便黄赤。脉弦稍数,舌苔黄腻。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,20日后痊愈。
15、成某,女,38岁.演员,2013年8月2日初诊。初诊:面部起紫暗之斑点数处斑连成片,额部较少,颐颏较多,高出皮肤,奇痒难忍,腹部亦有色紫如钱币小之斑,脱白屑。舌红,脉细滑稍数。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,10日后痊愈。
16、李某,男,18岁,工人,2013年4月17日初诊。初诊:手背、肢背湿疹破溃流水,湿烂奇痒,干后结黑痂,痂落后,又流水湿烂,随落随起,缠绵数月,以致精神萎靡,影响睡眠、食欲,经多方了治疗不效。诊脉弦滑,舌苔白稍腻。此症由脾不健运,湿邪久羁,留于四末,再加血分素有邪热,湿热结毒而致,故拟活血清热,理脾除湿之剂。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,一月后痊愈。
17、柴某某,男.38岁,2014年9月2日初诊。主诉:全身泛发皮疹,反复不愈已3年。现病史:3年前冬季开始在两小腿起两小片集簇之丘疱疹,发痒,搔破后水,久治不愈,范围越见扩大,1年前冬季渐散至胸、腹、背部。平时胃脘部痛,纳食不思,食后腹胀,不敢食生冷水果,大便日2~3次,完谷不化,便溏。查体:胸、腹及后背、四肢可见成片红斑、丘疹及集簇之丘疱疹,渗水糜烂,搔痕结痂,部分呈暗褐色,瘙痒无度。舌质淡、苔薄白腻,脉缓滑。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,两月后痊愈。
18、田某某,男,24岁,2014年3月13日初诊。主诉:全身出现红色小疙瘩瘙痒已1个月。现病史:近1个月来四肢、躯干初起红色小疙瘩,搔抓后出水,全身泛发,尤以上臂和两大腿部为重,曾服汤药和注射硫代硫酸钠等未见改善。查体:遍身可见散在粟粒样稍有渗水之红色丘疱疹,以四肢为明显,呈对称性和弥漫性损害。舌淡红、苔净,脉缓。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,15日后痊愈。
19、周某某,女,43岁,2010年2月28日初诊。主诉:两耳后脱屑发痒1年,3周来加重。现病史:1年来曾于二耳后脱屑发痒,3周前皮损逐渐扩展至耳廓、颈项侧面,皮肤浸润,潮红脱屑,部分渗水,瘙痒颇剧。下颌亦有小片流水皮损。查体:两耳后及耳廓部皮肤浸润,稍见鳞屑,部分流水、糜烂、结痂,下颌部可见不整形小片红斑及丘疱疹。两颊及鼻部毛孔扩大,皮脂溢出,并见毛细血管扩张。舌质红、苔薄白,脉滑
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,20日后痊愈。
20、郭某某,女,33岁,2010年9月14日初诊。主诉:头面等处瘙痒、脱屑2年多。现病史:2年来开始头皮瘙痒,抓后起小疙瘩,随后前额、脸面亦起鳞屑,半年后耳、项间亦潮红出现鳞屑。头发、眉毛易于脱落,逐渐稀疏。查体:前发际亦沿前额周围可见大片潮红和细薄鳞屑、黄痂,眉间、两颊亦见类似之损害,眉毛部分脱落,明显稀疏。双耳廓、颈项迹见大片潮红浸润、脱屑。舌淡、苔薄白,脉细弦滑。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,一月后痊愈。
21、郭某某,男,一岁半,2013年5月1日初诊。主诉:其父代诉患儿湿疹已1年多。现病史:患儿出生后2个月脸面即起红斑丘疹,经常消化不良喂奶期大便溏泻,长大后食量大,但食后不久即便出,完谷不化,常哭闹不安。查体:身体消瘦,面色胱白,头皮、脸面可见成片丘疱疹,正常皮色,不红,腹部及两腿亦起同样皮疹,呈淡褐色,渗出不多。舌淡红,苔薄白,脉沉缓。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,10日后痊愈。
22、陈某某,女,21岁。2011年5月26日初诊。主诉:颜面及双上肢起疙瘩作痒10天。现病史:10天来颜面及双手起小疙瘩,明显瘙痒,抓后津水、糜烂,由于瘙痒影响睡眠。大便4日未解,尿黄赤,月经正常。诊为急性湿疹。检查:体温38℃。颜面及耳部浮肿。两目不能睁视。皮色潮红,皮损津水及结痂,尤以两耳部为甚,双手及双前臂糜烂、结痂,部分脱落。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,10日后痊愈。
23、侯某某,女,20岁,2015年8月20日初诊。主诉:四肢起疙瘩作痒3年余。现病史:3年来,四肢起红色小疙瘩,每年冬轻夏重,6、7月份即复发。此次发病已月余,四肢泛发丘疹、水疱,津水作痒,糜烂处痛痒兼作,影响睡眠。大便时干,月经正常,平素白带量多。诊为慢性湿疹。检查:皮肤粗糙。四肢泛发丘疹及水疱,双足内踝部最重,皮损结痂、渗血水,有抓痕。舌苔薄白,脉弦滑。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,45天后痊愈。
24、尹某,女,27岁。初诊:全身起红疹瘙痒已有句日,抓破之后,则渗黏水,此湿火内盛,充斥肌表。治宜清化。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,13日后痊愈。
25、李某,男,43岁。初诊:两足背起湿疹已4个月,瘙痒流津,久治无效。治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,20日后痊愈。
26、陈某某,男,38岁。初诊:患湿疹已3年,过去都是生于足部,发于夏季。今年1月开始,先从右足小腿出现红疹瘙痒,用药3天之后引起过敏,皮肤红赤渗水,范围逐渐扩大。延及小腿肚及前胫,而后右足背、左胭窝、两耳后及两手部亦皆出现同样病变经过治疗,症状逐渐好转,但两小腿还有红疹出现,皮肤暗红,痒已止而尚感则痛,舌质红,口腔破碎。由湿热内蕴,外越皮肤。兹拟清热化湿之法调治。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,一月后痊愈。
27、束某某,女,59岁。初诊:患者两下肢起疹子,瘙痒流津已3年,自购各种成药及地方诊所打针,未能见效。诊得两下肢静脉曲张小腿胫前皮肤干燥增厚,边缘较清,上布丘疹,抓破处糜烂结痂,若树皮状,瘙痒不已,入夜更甚,背部亦有同样轻度损害。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,35日后痊愈。
28、梁某,女,中年,教师。初诊:皮肤瘙痒3年余,泛发暗红色斑丘疹,始发于两小腿,渐至全身,痒甚,严重时渗水。病初起时用抗过敏药尚能控制,病随日进,以致服药亦不起作用。痒甚时,虽搔破皮肤犹不能解。近1年来,症情加重,反复发作,缠绵不愈,每每彻夜不眠,不能正常工作。曾入某医院治疗效果不显。出院后,又经多方治疗不效,故就诊于余。患者瘙痒难忍,昼夜不得安静,全身不适,疲乏无力,纳谷不香,视其全身泛发暗红色斑丘疹,四肢内侧较重,除面部外,全身皮肤粗糙而干:有抓痕血痂,舌质红,苔白腻,脉浮缓而数。证属风湿久羁,蕴成热毒。治以疏风清热,除湿止痒。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,45日后痊愈。
29、麦某,男,57岁,已婚。初诊:于3个月前,胸部先出现散发性丘疹状似粟米,瘙痒无度,而两腋下版背、上肢遍发,并杂有脓疱,逐渐延及脐下、髂腰、阴囊、臀部、大腿、足踝搔抓出津,有的糜烂结有脓痂。全身伴有寒热往来,胃纳不佳,大便干结,3日未行,尿黄且短,口干不多饮。患者曾在某院诊治,未效。检查:日前皮损情况,胸背及上肢有散发性丘疹,夹有脱屑,脐下到两足踝之上遍发丘疹,糜烂结痂,津水流溢,夹有抓痕、血痂及白色脱屑,尤以两大腿内侧为甚。湿热逗留脏腑,内不得疏泄,为病之本;蕴伏肌肤,外不得透达,为病之标。苔薄黄,脉弦细。故治当清热利湿,佐以通腑利尿,以冀湿热之邪从二便下达。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,20日后痊愈。
30、赵某,女,26岁,工人。2013年5月13日初诊。初诊:两手素有湿疹,反复发作已数年。近日因接触化学药品,遍发红斑、丘疹、水疱,瘙痒,糜烂结痂,延及前臂。曾用癣药水,使病情加重。再到某医院皮肤科诊治,外涂可的松、地塞米松、氟轻松等药膏,注射葡萄糖酸钙、硫代硫酸钠等皆不效。日前正是急性发作,水疱满布,部分红肿糜烂,大便2日未行,口干渴。苔薄舌红,脉弦细。拟清热利湿。
治疗:服用本实施例的解毒胶囊,一日三次,每次5粒,20日后痊愈。
实施例2。
本实施例提供一种治疗湿疹的解毒制剂,是由如下重量份数的原料组成的:柴胡9份、黄芪20份、金银花9份、连翘9份、斑蝥6份、蝎子20份。
实施例3。
本实施例提供一种治疗湿疹的解毒制剂,是由如下重量份数的原料组成的:柴胡6份、黄芪15份、金银花6份、连翘6份、斑蝥3份、蝎子10份。
Claims (6)
1.一种治疗湿疹的解毒制剂,其特征在于,是由如下原料组成的:柴胡1~15份、黄芪3~30份、金银花1~15份、连翘1~15份、斑蝥0.5~10份、蝎子1~30份。
2.如权利要求1所述的治疗湿疹的解毒制剂,其特征在于,是由如下重量份数的原料组成的:柴胡5份、黄芪10份、金银花5份、连翘5份、斑蝥0.5份、蝎子100份。
3.如权利要求2所述的治疗湿疹的解毒制剂,其特征在于,是由如下原料组成的:柴胡9份、黄芪20份、金银花9份、连翘9份、斑蝥6份、蝎子20份。
4.如权利要求3所述的治疗湿疹的解毒制剂,其特征在于,是由如下重量份数的原料组成的:柴胡6份、黄芪15份、金银花6份、连翘6份、斑蝥3份、蝎子10份。
5.如权利要求1-4所述的治疗湿疹的解毒制剂的制备方法,其特征在于:按配方重量份数将柴胡、黄芪、金银花、连翘大火烧开,小火煎30min,反复煎煮三次,合并药汁,浓缩后干燥打粉,用20~80目过筛,得混合粉;再按照配方重量份数将斑蝥、蝎子打粉,用20~80目过筛后,与所述混合粉混匀,灌装成胶囊,即得。
6.如权利要求1所述的治疗湿疹的解毒制剂的制备方法,其特征在于,所述治疗湿疹的解毒制剂为胶囊剂、散剂等。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610018307.3A CN105535117A (zh) | 2016-01-13 | 2016-01-13 | 一种治疗湿疹的解毒制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610018307.3A CN105535117A (zh) | 2016-01-13 | 2016-01-13 | 一种治疗湿疹的解毒制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105535117A true CN105535117A (zh) | 2016-05-04 |
Family
ID=55815042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610018307.3A Pending CN105535117A (zh) | 2016-01-13 | 2016-01-13 | 一种治疗湿疹的解毒制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535117A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562324A (zh) * | 2004-04-16 | 2005-01-12 | 李有凤 | 一种治疗湿疹的外用药物 |
CN101057903A (zh) * | 2007-05-16 | 2007-10-24 | 北京艺信堂医药研究所 | 一种治疗急性湿疹的中药制剂 |
CN101176765A (zh) * | 2007-01-16 | 2008-05-14 | 张文武 | 一种中药解毒制剂及其制备方法 |
CN105169224A (zh) * | 2015-08-11 | 2015-12-23 | 王义朋 | 一种治疗银屑病的中药粉剂 |
-
2016
- 2016-01-13 CN CN201610018307.3A patent/CN105535117A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562324A (zh) * | 2004-04-16 | 2005-01-12 | 李有凤 | 一种治疗湿疹的外用药物 |
CN101176765A (zh) * | 2007-01-16 | 2008-05-14 | 张文武 | 一种中药解毒制剂及其制备方法 |
CN101057903A (zh) * | 2007-05-16 | 2007-10-24 | 北京艺信堂医药研究所 | 一种治疗急性湿疹的中药制剂 |
CN105169224A (zh) * | 2015-08-11 | 2015-12-23 | 王义朋 | 一种治疗银屑病的中药粉剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
CN103705751A (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
CN102846955A (zh) | 一种中药增高鞋垫 | |
CN104189196A (zh) | 一种治疗下肢静脉曲张的中药 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN100421722C (zh) | 治疗风寒骨刺的膏药 | |
CN101322756B (zh) | 用于推拿按摩治疗腰椎病症的药物及其制备方法 | |
CN102641368A (zh) | 一种治疗脚气的中药 | |
CN102988833B (zh) | 一种治疗风湿病的中药组合物 | |
CN102961472A (zh) | 一种治疗妇女产后风湿的中药组合物 | |
CN102579975A (zh) | 一种治疗银屑病的中药混合物 | |
CN103041226B (zh) | 一种治疗膝关节积液的中药 | |
CN102406865A (zh) | 一种治疗银屑病的中药组合物 | |
CN105641330A (zh) | 一种补肾壮阳的中药组合物 | |
CN105616536A (zh) | 一种治疗白癜风的中药擦剂 | |
CN100571725C (zh) | 一种治疗坐骨神经痛的中药制剂 | |
CN101116711A (zh) | 一种治疗产后小便失禁的中药组合物 | |
CN105535117A (zh) | 一种治疗湿疹的解毒制剂 | |
CN103751656A (zh) | 一种治疗尿浊病的中药汤剂 | |
CN106806445A (zh) | 一种用于治疗白癜风的中药组合物 | |
CN106310172A (zh) | 一种治疗疼痛性疾病的膏泥膜药物及其制备方法和用途 | |
CN105521391A (zh) | 一种补肝肾强筋骨的中药及其制备方法 | |
CN105663383A (zh) | 一种强身壮阳的中药组合物 | |
CN105664143A (zh) | 一种强身壮阳的药物组合物及其制备方法 | |
CN106552215A (zh) | 一种祛湿杀虫中药足浴养生保健方剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160504 |